BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685-1690. [PMID: 8637512 DOI: 10.1056/nejm199606273342601] [Cited by in Crossref: 1272] [Cited by in F6Publishing: 148] [Article Influence: 50.9] [Reference Citation Analysis]
Number Citing Articles
1 Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 2006;12:7239-49. [PMID: 17143937 DOI: 10.3748/wjg.v12.i45.7239] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
2 Raghwani J, Thomas XV, Koekkoek SM, Schinkel J, Molenkamp R, van de Laar TJ, Takebe Y, Tanaka Y, Mizokami M, Rambaut A, Pybus OG. Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. J Virol 2012;86:2212-20. [PMID: 22114341 DOI: 10.1128/JVI.06184-11] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
3 Sen Gupta A. Bio-inspired nanomedicine strategies for artificial blood components. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017;9. [PMID: 28296287 DOI: 10.1002/wnan.1464] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
4 Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am 2010;24:899-919, viii. [PMID: 20937457 DOI: 10.1016/j.idc.2010.07.004] [Cited by in Crossref: 120] [Cited by in F6Publishing: 100] [Article Influence: 12.0] [Reference Citation Analysis]
5 Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K. Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010;14:R92. [PMID: 20497535 DOI: 10.1186/cc9026] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
6 Cip J, Widemschek M, Benesch T, Waibel R, Martin A. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial. Clin Orthop Relat Res 2013;471:1319-25. [PMID: 23229426 DOI: 10.1007/s11999-012-2729-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shinde A, Sobti A, Maniar S, Mishra A, Gite R, Shetty V. Tranexamic acid reduces blood loss and need of blood transfusion in total knee arthroplasty: A prospective, randomized, double-blind study in Indian population. Asian J Transfus Sci 2015;9:168-72. [PMID: 26420938 DOI: 10.4103/0973-6247.154251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
8 Drosten C, Seifried E, Roth WK. TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J Clin Microbiol 2001;39:4302-8. [PMID: 11724836 DOI: 10.1128/JCM.39.12.4302-4308.2001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
9 Carneiro-Proietti AB, Sabino EC, Leão S, Salles NA, Loureiro P, Sarr M, Wright D, Busch M, Proietti FA, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II (Reds-II), International Component. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. AIDS Res Hum Retroviruses 2012;28:1265-72. [PMID: 22324906 DOI: 10.1089/AID.2011.0143] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
10 Li L, Han T, Zang L, Niu L, Cheng W, Lin H, Li KY, Cao R, Zhao B, Liu Y, Ou G, Liu X, Qi Y, Li Y, Liu Z. The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China. BMC Infect Dis 2017;17:754. [PMID: 29212443 DOI: 10.1186/s12879-017-2861-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Barosi G, Marchetti M, Liberato NL. Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia. Br J Cancer 1998;78:781-7. [PMID: 9743301 DOI: 10.1038/bjc.1998.579] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
12 Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67:1053-1076. [PMID: 17488147 DOI: 10.2165/00003495-200767070-00007] [Cited by in Crossref: 190] [Cited by in F6Publishing: 135] [Article Influence: 13.6] [Reference Citation Analysis]
13 Ramsey G. Blood component recalls and market withdrawals: frequency, reasons, and management in the United States. Transfus Med Rev 2013;27:82-90. [PMID: 23375736 DOI: 10.1016/j.tmrv.2012.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lo Re V 3rd, Kostman JR. Management of chronic hepatitis C. Postgrad Med J 2005;81:376-82. [PMID: 15937203 DOI: 10.1136/pgmj.2004.025403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
15 de Almeida Pondé RA. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach. Mol Biol Rep 2021;48:843-54. [PMID: 33296069 DOI: 10.1007/s11033-020-06056-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Le Roux PD; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care 2011;15:342-53. [PMID: 21769459 DOI: 10.1007/s12028-011-9582-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
17 Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005;18:12-29. [PMID: 15653816 DOI: 10.1128/CMR.18.1.12-29.2005] [Cited by in Crossref: 129] [Cited by in F6Publishing: 35] [Article Influence: 8.1] [Reference Citation Analysis]
18 Grubyte S, Urboniene J, Nedzinskiene L, Jelinskaite A, Zagminas K, Ambrozaitis A, Jancoriene L. Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study. PLoS One 2021;16:e0246704. [PMID: 33606700 DOI: 10.1371/journal.pone.0246704] [Reference Citation Analysis]
19 Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74. [PMID: 19330875 DOI: 10.1002/hep.22759] [Cited by in Crossref: 2134] [Cited by in F6Publishing: 1886] [Article Influence: 177.8] [Reference Citation Analysis]
20 Levi JE, Pereira RA, Polite MB, Mota MA, Nunez SP, Pinho JR, Kutner JM. One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus. Rev Bras Hematol Hemoter 2013;35:167-70. [PMID: 23904804 DOI: 10.5581/1516-8484.20130039] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Kengne M, Tsata DCW, Ndomgue T, Nwobegahay JM. Prevalence and risk factors of HTLV-1/2 and other blood borne infectious diseases among blood donors in Yaounde Central Hospital, Cameroon. Pan Afr Med J 2018;30:125. [PMID: 30374371 DOI: 10.11604/pamj.2018.30.125.14802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Velati C, Romanò L, Piccinini V, Marano G, Catalano L, Pupella S, Facco G, Pati I, Tosti ME, Vaglio S, Grazzini G, Zanetti A, Liumbruno GM. Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey. Blood Transfus 2018;16:422-32. [PMID: 30036178 DOI: 10.2450/2018.0069-18] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
23 Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA; National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study., Retrovirus Epidemiology Donor Study-II. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev 2012;26:281-304, 304.e1-2. [PMID: 22633182 DOI: 10.1016/j.tmrv.2012.04.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
24 Zhang HQ, Li SB, Wang GH, Chen K, Song XG, Feng XY. Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China. World J Gastroenterol 2007;13:2738-42. [PMID: 17569145 DOI: 10.3748/wjg.v13.i19.2738] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
25 Blatyta PF, Custer B, Gonçalez TT, Birch R, Lopes ME, Lopes Ferreira MI, Carneiro Proietti AB, Sabino EC, Page K, de Almeida-Neto C; NHLBI Retrovirus Epidemiology Donor Study-II International Component. Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil. Transfusion 2013;53:2734-43. [PMID: 23521083 DOI: 10.1111/trf.12166] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
26 Solves P, Mirabet V, Alvarez M. Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? World J Gastroenterol 2014;20:7434-41. [PMID: 24966613 DOI: 10.3748/wjg.v20.i23.7434] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
27 Husic-Selimovic A, Sofic A, Jahic E, Prohic D, Merhemic Z. Impact of Different Sources of Infection on Therapy Response in Chronic Hepatitis C. Med Arch 2018;72:182-6. [PMID: 30061763 DOI: 10.5455/medarh.2018.72.182-186] [Reference Citation Analysis]
28 Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011;2:7-21. [PMID: 22287859 DOI: 10.2147/JBM.S17194] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
29 Nkrumah B, Owusu M, Averu P. Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana. BMC Res Notes 2011;4:529. [PMID: 22152159 DOI: 10.1186/1756-0500-4-529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
30 O'Brien SF, Zou S, Laperche S, Brant LJ, Seed CR, Kleinman SH. Surveillance of transfusion-transmissible infections comparison of systems in five developed countries. Transfus Med Rev 2012;26:38-57. [PMID: 21944935 DOI: 10.1016/j.tmrv.2011.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
31 Hickman DA, Pawlowski CL, Shevitz A, Luc NF, Kim A, Girish A, Marks J, Ganjoo S, Huang S, Niedoba E, Sekhon UDS, Sun M, Dyer M, Neal MD, Kashyap VS, Sen Gupta A. Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage. Sci Rep 2018;8:3118. [PMID: 29449604 DOI: 10.1038/s41598-018-21384-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
32 Tran HA, Jones TL, Ianna EA, Foy A, Reeves GE. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective. Endocr Pract 2013;19:292-300. [PMID: 23186968 DOI: 10.4158/EP12195.RA] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Skelly AN, Kolla L, Tamburro MK, Bar KJ. Science over stigma: the need for evidence-based blood donation policies for men who have sex with men in the USA. Lancet Haematol 2020;7:e779-82. [PMID: 33091347 DOI: 10.1016/S2352-3026(20)30326-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Yang C, Pieniazek D, Owen SM, Fridlund C, Nkengasong J, Mastro TD, Rayfield MA, Downing R, Biryawaho B, Tanuri A, Zekeng L, van der Groen G, Gao F, Lal RB. Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999;37:2581-6. [PMID: 10405405 DOI: 10.1128/JCM.37.8.2581-2586.1999] [Cited by in Crossref: 58] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
35 Diiorio TM, Burkholder JD, Good RP, Parvizi J, Sharkey PF. Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin Orthop Relat Res 2012;470:138-43. [PMID: 21748512 DOI: 10.1007/s11999-011-1972-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
36 Mohsen AH; Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001;48:707-13. [PMID: 11302973 DOI: 10.1136/gut.48.5.707] [Cited by in Crossref: 69] [Cited by in F6Publishing: 78] [Article Influence: 3.5] [Reference Citation Analysis]
37 Jabbour N, Gagandeep S, Mateo R, Sher L, Strum E, Donovan J, Kahn J, Peyre CG, Henderson R, Fong TL, Selby R, Genyk Y. Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg. 2004;240:350-357. [PMID: 15273561 DOI: 10.1097/01.sla.0000133352.25163.fd] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
38 Fessehaye N, Naik D, Fessehaye T. Transfusion transmitted infections - a retrospective analysis from the National Blood Transfusion Service in Eritrea. Pan Afr Med J 2011;9:40. [PMID: 22145069 DOI: 10.4314/pamj.v9i1.71219] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
39 Maity S, Nandi S, Biswas S, Sadhukhan SK, Saha MK. Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India. Virol J. 2012;9:290. [PMID: 23181517 DOI: 10.1186/1743-422x-9-290] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
40 Saadeh Y, Vyas D. Nanorobotic Applications in Medicine: Current Proposals and Designs. Am J Robot Surg 2014;1:4-11. [PMID: 26361635 DOI: 10.1166/ajrs.2014.1010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
41 Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2. Clin Diagn Lab Immunol 2003;10:715-7. [PMID: 12853410 DOI: 10.1128/cdli.10.4.715-717.2003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial. Hip Int 2014;24:63-8. [PMID: 24062227 DOI: 10.5301/hipint.5000090] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
43 Menendez ME, Ring D. Minorities are less likely to receive autologous blood transfusion for major elective orthopaedic surgery. Clin Orthop Relat Res 2014;472:3559-66. [PMID: 25028107 DOI: 10.1007/s11999-014-3793-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
44 López-Menchero C, Alvarez M, Fernández P, Guzmán M, Ortiz-de-Salazar MI, Arbona C. Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017). Blood Transfus 2019;17:418-27. [PMID: 31403928 DOI: 10.2450/2019.0058-19] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
45 Cicchetti A, Berrino A, Casini M, Codella P, Facco G, Fiore A, Marano G, Marchetti M, Midolo E, Minacori R, Refolo P, Romano F, Ruggeri M, Sacchini D, Spagnolo AG, Urbina I, Vaglio S, Grazzini G, Liumbruno GM. Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use. Blood Transfus 2016;14:287-386. [PMID: 27403740 DOI: 10.2450/2016.0065-16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Klika AK, Small TJ, Saleh A, Szubski CR, Chandran Pillai AL, Barsoum WK. Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009. J Arthroplasty 2014;29:2070-7. [PMID: 25073900 DOI: 10.1016/j.arth.2014.06.018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 7.9] [Reference Citation Analysis]
47 Velati C, Romanò L, Pati I, Marano G, Piccinini V, Catalano L, Pupella S, Vaglio S, Veropalumbo E, Masiello F, Pisani G, Grazzini G, Zanetti A, Liumbruno GM. Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018. Blood Transfus 2019;17:409-17. [PMID: 31846606 DOI: 10.2450/2019.0245-19] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Alessandrelli F, Mazzella G. Lamivudine treatment for severe acute HBV hepatitis. Int J Med Sci 2008;5:309-12. [PMID: 18974858 DOI: 10.7150/ijms.5.309] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
49 Li W, Gao Z, Yang C, Li J, Li L, Lv R, Liu Z. The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PLoS One 2013;8:e73472. [PMID: 24058476 DOI: 10.1371/journal.pone.0073472] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lo Re V 3rd, Kostman JR, Amorosa VK. Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis 2008;12:587-609, ix. [PMID: 18625430 DOI: 10.1016/j.cld.2008.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
51 Hejblum G, Setbon M, Temime L, Lesieur S, Valleron AJ. Modelers' perception of mathematical modeling in epidemiology: a web-based survey. PLoS One 2011;6:e16531. [PMID: 21304976 DOI: 10.1371/journal.pone.0016531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Saber HR, Tabatabaee SM, Abasian A, Jamali M, SalekMoghadam E, Hajibeigi B, Alavian SM, Mirrezaie SM. Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran. Indian J Hematol Blood Transfus 2017;33:412-6. [PMID: 28824247 DOI: 10.1007/s12288-016-0732-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
53 Ferraris VA, Ferraris SP, Saha SP. Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations. Int J Angiol 2011;20:1-18. [PMID: 22532765 DOI: 10.1055/s-0031-1272544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
54 Abravaya K, Esping C, Hoenle R, Gorzowski J, Perry R, Kroeger P, Robinson J, Flanders R. Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2. J Clin Microbiol 2000;38:716-23. [PMID: 10655373 DOI: 10.1128/JCM.38.2.716-723.2000] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
55 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
56 Sulkowski MS. Hepatitis C virus infection in HIV-infected patients. Curr Infect Dis Rep 2007;3:469-76. [PMID: 24395487 DOI: 10.1007/s11908-007-1004-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
57 Gupta P. Hepatitis C Virus and HIV Type 1 Co-Infection. Infect Dis Rep 2013;5:e7. [PMID: 24470971 DOI: 10.4081/idr.2013.s1.e7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
58 Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis 1998;4:5-11. [PMID: 9452393 DOI: 10.3201/eid0401.980102] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
59 Kuklina EV, Meikle SF, Jamieson DJ, Whiteman MK, Barfield WD, Hillis SD, Posner SF. Severe obstetric morbidity in the United States: 1998-2005. Obstet Gynecol 2009;113:293-9. [PMID: 19155897 DOI: 10.1097/AOG.0b013e3181954e5b] [Cited by in Crossref: 137] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
60 Li T, Zhuang Q, Weng X, Zhou L, Bian Y. Non-continuous versus continuous wound drainage after total knee arthroplasty: a meta-analysis. Int Orthop 2014;38:361-71. [PMID: 24048445 DOI: 10.1007/s00264-013-2105-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diagn 2000;5:11-22. [PMID: 10837085 DOI: 10.1007/BF03262018] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
62 Cai K, Gierman TM, Hotta J, Stenland CJ, Lee DC, Pifat DY, Petteway SR Jr. Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens. BioDrugs 2005;19:79-96. [PMID: 15807628 DOI: 10.2165/00063030-200519020-00002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
63 Gröner A. Pathogen safety of plasma-derived products - Haemate P/Humate-P. Haemophilia 2008;14 Suppl 5:54-71. [PMID: 18786011 DOI: 10.1111/j.1365-2516.2008.01852.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
64 Nafishah A, Asiah MN, Syimah AT, Mohd Zahari TH, Yasmin A, Normi M, Anza E, Shahnaz M, Narazah MY. Rate of seroconversion in repeat blood donors at the national blood centre, kuala lumpur. Indian J Hematol Blood Transfus. 2014;30:105-110. [PMID: 24839364 DOI: 10.1007/s12288-012-0213-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
65 Sakudo A, Suganuma Y, Kobayashi T, Onodera T, Ikuta K. Near-infrared spectroscopy: promising diagnostic tool for viral infections. Biochem Biophys Res Commun 2006;341:279-84. [PMID: 16414011 DOI: 10.1016/j.bbrc.2005.12.153] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
66 Barbara JA. The rationale for pathogen-inactivation treatment of blood components. Int J Hematol 2004;80:311-6. [PMID: 15615254 DOI: 10.1532/ijh97.04120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care 2004;8 Suppl 2:S18-23. [PMID: 15196317 DOI: 10.1186/cc2847] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
68 Herd JM, Joseph JJ, McGarvey M, Tsimbouri P, Bennett A, Meek RM, Morrison A. Intraoperative cell salvage in revision hip surgery. Ann Med Surg (Lond) 2014;3:8-12. [PMID: 25568779 DOI: 10.1016/j.amsu.2013.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
69 Spada E, Sagliocca L, Sourdis J, Garbuglia AR, Poggi V, De Fusco C, Mele A. Use of the minimum spanning tree model for molecular epidemiological investigation of a nosocomial outbreak of hepatitis C virus infection. J Clin Microbiol 2004;42:4230-6. [PMID: 15365016 DOI: 10.1128/JCM.42.9.4230-4236.2004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
70 Kasat K, Hendricks-Muñoz KD, Mally PV. Neonatal red blood cell transfusions: searching for better guidelines. Blood Transfus 2011;9:86-94. [PMID: 21235854 DOI: 10.2450/2010.0031-10] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
71 Gonçalez TT, Sabino EC, Salles NA, de Almeida-Neto C, Mendrone A Jr, Dorlhiac-Laccer PE, Liu J, Murphy EL, Schreiber GB; REDS-II International Brazil Study. The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil. Transfusion 2010;50:909-17. [PMID: 20003056 DOI: 10.1111/j.1537-2995.2009.02526.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
72 Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013;19:850-8. [PMID: 23836235 DOI: 10.1038/nm.3184] [Reference Citation Analysis]
73 Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011;469:2874-80. [PMID: 21512813 DOI: 10.1007/s11999-011-1874-2] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 9.4] [Reference Citation Analysis]
74 Hyde GK, Stewart SM, Scarel G, Parsons GN, Shih CC, Shih CM, Lin SJ, Su YY, Monteiro-Riviere NA, Narayan RJ. Atomic layer deposition of titanium dioxide on cellulose acetate for enhanced hemostasis. Biotechnol J 2011;6:213-23. [PMID: 21298806 DOI: 10.1002/biot.201000342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
75 Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013;19:850-8. [PMID: 23836235 DOI: 10.1038/nm.3184] [Cited by in Crossref: 205] [Cited by in F6Publishing: 196] [Article Influence: 25.6] [Reference Citation Analysis]
76 McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 2002;324:1299. [PMID: 12039820 DOI: 10.1136/bmj.324.7349.1299] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
77 Regan FA, Hewitt P, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group. BMJ 2000;320:403-6. [PMID: 10669443 DOI: 10.1136/bmj.320.7232.403] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
78 Islam MM, Hossain F, Sakib N, Zeba Z, Bhuiyan AKMI, Mamun MA, Kaggwa MM, Yoshimura K, Afrin S, Selim S, Hossain M. Distribution of β-Thalassemia and Other Hemoglobinopathies in Bangladeshi University Students and Ready-Made Garment Workers. Risk Manag Healthc Policy 2021;14:2707-14. [PMID: 34194252 DOI: 10.2147/RMHP.S317852] [Reference Citation Analysis]
79 Kim YT, Kang MW, Lee JK, Lee YM, Kim JI. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. BMC Musculoskelet Disord 2018;19:227. [PMID: 30021575 DOI: 10.1186/s12891-018-2151-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
80 Osaro E, Mohammed N, Zama I, Yakubu A, Dorcas I, Festus A, Kwaifa I, Sani I. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria--the question of safety of blood transfusion in Nigeria. Pan Afr Med J 2014;18:174. [PMID: 25419301 DOI: 10.11604/pamj.2014.18.174.3449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
81 Tolentino YF, Fogaca HS, Zaltman C, Ximenes LL, Coelho HS. Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital. World J Gastroenterol. 2008;14:3201-3206. [PMID: 18506926 DOI: 10.3748/wjg.14.3201] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
82 Greenburg AG, Kim HW. Hemoglobin-based oxygen carriers. Crit Care 2004;8 Suppl 2:S61-4. [PMID: 15196328 DOI: 10.1186/cc2455] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
83 Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One 2014;9:e94528. [PMID: 24714490 DOI: 10.1371/journal.pone.0094528] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
84 Rogers MA, Rohde JM, Blumberg N. Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries. Vox Sang 2016;110:266-77. [PMID: 26689441 DOI: 10.1111/vox.12367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
85 Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011;8:96. [PMID: 21375724 DOI: 10.1186/1743-422X-8-96] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
86 Kupek E, Petry A. Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil. J Transfus 2011;2011:985383. [PMID: 25346858 DOI: 10.4061/2011/985383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
87 Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer 2013;13:136-48. [PMID: 24156033 DOI: 10.5230/jgc.2013.13.3.136] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 9.9] [Reference Citation Analysis]
88 de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, Leão SC, Wright DJ, Basques FV, Ferreira JE, Busch MP, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion 2013;53:827-34. [PMID: 22882510 DOI: 10.1111/j.1537-2995.2012.03840.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
89 Gross AE, Kim W, Heras FL, Backstein D, Safir O, Pritzker KPH. Fresh osteochondral allografts for posttraumatic knee defects: Long-term followup. Clin Orthop Relat Res. 2008;466:1863-1870. [PMID: 18465182 DOI: 10.1007/s11999-008-0282-8] [Cited by in Crossref: 165] [Cited by in F6Publishing: 125] [Article Influence: 12.7] [Reference Citation Analysis]
90 Ma ZM, Stone M, Piatak M Jr, Schweighardt B, Haigwood NL, Montefiori D, Lifson JD, Busch MP, Miller CJ. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol 2009;83:3288-97. [PMID: 19129448 DOI: 10.1128/JVI.02423-08] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
91 Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, de Luigi C, Crovari P. Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J Clin Microbiol 2001;39:3110-4. [PMID: 11526137 DOI: 10.1128/JCM.39.9.3110-3114.2001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
92 Laing RW, Bhogal RH, Wallace L, Boteon Y, Neil DAH, Smith A, Stephenson BTF, Schlegel A, Hübscher SG, Mirza DF, Afford SC, Mergental H. The Use of an Acellular Oxygen Carrier in a Human Liver Model of Normothermic Machine Perfusion. Transplantation 2017;101:2746-56. [PMID: 28520579 DOI: 10.1097/TP.0000000000001821] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
93 Lansdale M, Castellino S, Marina N, Goodman P, Hudson MM, Mertens AC, Smith SM, Leisenring W, Robison LL, Oeffinger KC. Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer 2010;116:974-82. [PMID: 20041485 DOI: 10.1002/cncr.24810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
94 Jeon YS, Park JS, Kim MK. Optimal release timing of temporary drain clamping after total knee arthroplasty. J Orthop Surg Res 2017;12:47. [PMID: 28327167 DOI: 10.1186/s13018-017-0550-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Goncalez T, Sabino E, Sales N, Chen YH, Chamone D, Busch M, Murphy E, Custer B, McFarland W. Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil. Transfusion 2010;50:1806-14. [PMID: 20456699 DOI: 10.1111/j.1537-2995.2010.02650.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
96 Hanna SA, Prasad A, Lee J, Achan P. Topical Versus Intravenous Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Orthop Rev (Pavia) 2016;8:6792. [PMID: 27761223 DOI: 10.4081/or.2016.6792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
97 Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:47-52. [PMID: 16614742 DOI: 10.7150/ijms.3.47] [Cited by in Crossref: 454] [Cited by in F6Publishing: 416] [Article Influence: 30.3] [Reference Citation Analysis]
98 Williamson LM, Heptonstall J, Soldan K. A SHOT in the arm for safer blood transfusion. BMJ 1996;313:1221-2. [PMID: 8939097 DOI: 10.1136/bmj.313.7067.1221] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
99 Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol. 2009;15:3099-3105. [PMID: 19575488 DOI: 10.3748/wjg.15.3099] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
100 Murphy EL. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfus Clin Biol 2016;23:13-9. [PMID: 26778839 DOI: 10.1016/j.tracli.2015.12.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
101 Deuffic-Burban S, Abiteboul D, Lot F, Branger M, Bouvet E, Yazdanpanah Y. Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection. Gut 2009;58:105-10. [PMID: 18824553 DOI: 10.1136/gut.2007.145516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
102 Shittu AO, Olawumi HO, Adewuyi JO. Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank. Ghana Med J 2014;48:158-62. [PMID: 25709126 DOI: 10.4314/gmj.v48i3.7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
103 de Almeida-Neto C, Goncalez TT, Birch RJ, de Carvalho SM, Capuani L, Leão SC, Miranda C, Rocha PC, Carneiro-Proietti AB, Johnson BR, Wright DJ, Murphy EL, Custer B; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Component, Brazil. Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case-control study using audio computer-assisted structured interviews. Vox Sang 2013;105:91-9. [PMID: 23517235 DOI: 10.1111/vox.12028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
104 Shang G, Biggerstaff BJ, Yang B, Shao C, Farrugia A. Theoretically estimated risk of severe acute respiratory syndrome transmission through blood transfusion during an epidemic in Shenzhen, Guangdong, China in 2003. Transfus Apher Sci 2007;37:233-40. [PMID: 18036985 DOI: 10.1016/j.transci.2007.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
105 Ramkiran S, Kumar M, Krishnakumar L, Nair SG. Comparison of Blood-Conserving and Allogenic Transfusion-Sparing Effects of Antifibrinolytics in Scoliosis Correction Surgery. Anesth Essays Res 2020;14:259-65. [PMID: 33487826 DOI: 10.4103/aer.AER_59_20] [Reference Citation Analysis]
106 Cook LB, Melamed A, Demontis MA, Laydon DJ, Fox JM, Tosswill JH, de Freitas D, Price AD, Medcalf JF, Martin F, Neuberger JM, Bangham CR, Taylor GP. Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients. Retrovirology 2016;13:3. [PMID: 26745892 DOI: 10.1186/s12977-015-0236-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
107 Altuntas F, Sari I, Kocyigit I, Kaynar L, Hacioglu S, Ozturk A, Oztekin M, Solmaz M, Eser B, Cetin M, Unal A. Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators. Transfus Med Hemother 2008;35:368-73. [PMID: 21512626 DOI: 10.1159/000151351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
108 Schmeltzer P, Sherman KE. Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci. 2010;55:3328-3335. [PMID: 20927592 DOI: 10.1007/s10620-010-1413-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
109 Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012;12:160. [PMID: 22817275 DOI: 10.1186/1471-2334-12-160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
110 Gobbers E, Oosterlaken TA, van Bussel MJ, Melsert R, Kroes AC, Claas EC. Efficient extraction of virus DNA by NucliSens Extractor allows sensitive detection of hepatitis B virus by PCR. J Clin Microbiol 2001;39:4339-43. [PMID: 11724842 DOI: 10.1128/JCM.39.12.4339-4343.2001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
111 Brambilla DJ, Busch MP, Dodd RY, Glynn SA, Kleinman SH; National Heart, Lung, and Blood InstituteRecipient Epidemiology and Donor Evaluation Study-III (REDS-III). A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors. Transfusion 2017;57:823-31. [PMID: 27910095 DOI: 10.1111/trf.13939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
112 Kaźmierczak J, Pawełczyk A, Cortes KC, Radkowski M. Seronegative hepatitis C virus infection. Arch Immunol Ther Exp (Warsz) 2014;62:145-51. [PMID: 24202543 DOI: 10.1007/s00005-013-0257-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
113 Khan M, Mustafa MG, Ahmad N, Alam MS, Baig RH, Chowdhry ZR, Ahmed M. Seroprevalence of hepatitis C virus in rural population of Bangladesh. Indian J Gastroenterol 2010;29:38-9. [PMID: 20373087 DOI: 10.1007/s12664-010-0010-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med. 2014;4:a024935. [PMID: 25359547 DOI: 10.1101/cshperspect.a024935] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
115 Chassé M, McIntyre L, Tinmouth A, Acker J, English SW, Knoll G, Forster A, Shehata N, Wilson K, van Walraven C, Ducharme R, Fergusson DA. Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuum. BMJ Open 2015;5:e007412. [PMID: 25600255 DOI: 10.1136/bmjopen-2014-007412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
116 El-Sherif AM, Abou-Shady MA, Al-Hiatmy MA, Al-Bahrawy AM, Motawea EA. Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen. Hepatol Int. 2007;1:469-470. [PMID: 19669344 DOI: 10.1007/s12072-007-9017-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
117 Cobo F, Stacey GN, Hunt C, Cabrera C, Nieto A, Montes R, Cortés JL, Catalina P, Barnie A, Concha A. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol 2005;68:456-66. [PMID: 16012832 DOI: 10.1007/s00253-005-0062-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
118 Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion. 2008;48:1739-1753. [PMID: 18466171 DOI: 10.1111/j.1537-2995.2008.01717.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
119 Pondé RA. Hidden hazards of HCV transmission. Med Microbiol Immunol 2011;200:7-11. [PMID: 20461405 DOI: 10.1007/s00430-010-0159-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
120 Ramsey G. Managing recalls and withdrawals of blood components. Transfus Med Rev 2004;18:36-45. [PMID: 14689376 DOI: 10.1016/j.tmrv.2003.10.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
121 Hawi N, Kendoff DO, Hessling U, Haasper C, Gehrke T, Citak M. Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty. Int Orthop 2014;38:1603-8. [PMID: 24817099 DOI: 10.1007/s00264-014-2359-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
122 Morandi PA, Schockmel GA, Yerly S, Burgisser P, Erb P, Matter L, Sitavanc R, Perrin L. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol 1998;36:1534-8. [PMID: 9620372 DOI: 10.1128/JCM.36.6.1534-1538.1998] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
123 Vermeulen M, Chowdhury D, Swanevelder R, Grebe E, Brambilla D, Jentsch U, Busch M, Van Zyl G, Murphy EL; REDS-III International Program South Africa. HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods. Vox Sang 2021;116:71-80. [PMID: 32762088 DOI: 10.1111/vox.12987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
124 Fishman JA. Opportunistic infections--coming to the limits of immunosuppression? Cold Spring Harb Perspect Med. 2013;3:a015669. [PMID: 24086067 DOI: 10.1101/cshperspect.a015669] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
125 Cho GJ, Oh MS, Oh MJ, Park KV, Han SW, Chae YK. Peripartum Blood Transfusions are Associated with Increased Risk of Cancer: A National Retrospective Cohort Study. Clin Epidemiol 2020;12:659-66. [PMID: 32606991 DOI: 10.2147/CLEP.S244443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Chow WZ, Bon AH, Keating S, Anderios F, Halim HA, Takebe Y, Kamarulzaman A, Busch MP, Tee KK. Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries. PLoS One 2016;11:e0161853. [PMID: 27575746 DOI: 10.1371/journal.pone.0161853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
127 Atalay H, Atalay A, Dogan OF. Local use of ankaferd blood clotter in emergent beating heart coronary artery bypass grafting. Open Cardiovasc Med J 2015;9:18-25. [PMID: 25834652 DOI: 10.2174/1874192401509010018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
128 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Cabrales P, Zhou Y, Harris DR, Palmer AF. Tissue oxygenation after exchange transfusion with ultrahigh-molecular-weight tense- and relaxed-state polymerized bovine hemoglobins. Am J Physiol Heart Circ Physiol 2010;298:H1062-71. [PMID: 20061539 DOI: 10.1152/ajpheart.01022.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
130 Chareancholvanich K, Siriwattanasakul P, Narkbunnam R, Pornrattanamaneewong C. Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskelet Disord. 2012;13:124. [PMID: 22817651 DOI: 10.1186/1471-2474-13-124] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
131 Galbraith DN. Regulatory and microbiological safety issues surrounding cell and tissue-engineering products. Biotechnol Appl Biochem 2004;40:35-9. [PMID: 15270705 DOI: 10.1042/BA20030163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Purkayastha S, Athanasiou T, Malinovski V, Tekkis P, Foale R, Casula R, Glenville B, Darzi A. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis. Heart 2006;92:531-2. [PMID: 16537769 DOI: 10.1136/hrt.2004.058396] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
133 Novitsky YW, Kercher KW, Czerniach DR, Litwin DE. Watermelon stomach: pathophysiology, diagnosis, and management. J Gastrointest Surg 2003;7:652-61. [PMID: 12850679 DOI: 10.1016/s1091-255x(02)00435-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
134 Tokin C, Almeda J, Jain S, Kim J, Henderson R, Nadim M, Sher L, Selby RR. Blood-management programs: a clinical and administrative model with program implementation strategies. Perm J 2009;13:18-28. [PMID: 21373242 DOI: 10.7812/tpp/08-029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Rerambiah LK, Rerambiah LE, Bengone C, Djoba Siawaya JF. The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus 2014;12:330-3. [PMID: 24333085 DOI: 10.2450/2013.0144-13] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
136 Hochreiter J, Hejkrlik W, Emmanuel K, Hitzl W, Ortmaier R. Blood loss and transfusion rate in short stem hip arthroplasty. A comparative study. Int Orthop. 2017;41:1347-1353. [PMID: 27942850 DOI: 10.1007/s00264-016-3365-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
137 Zhu Q, Li N, Zeng X, Han Q, Li F, Yang C, Lv Y, Zhou Z, Liu Z. Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival. Oncotarget. 2015;6:4440-4450. [PMID: 25686836 DOI: 10.18632/oncotarget.2913] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
138 Bejaoui M, Guirat N. Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects. Mediterr J Hematol Infect Dis 2013;5:e2013002. [PMID: 23350015 DOI: 10.4084/MJHID.2013.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
139 Aburawi MM, Fontan FM, Karimian N, Eymard C, Cronin S, Pendexter C, Nagpal S, Banik P, Ozer S, Mahboub P, Delmonico FL, Yeh H, Uygun K, Markmann JF. Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion. Am J Transplant 2019;19:2814-24. [PMID: 30938927 DOI: 10.1111/ajt.15375] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
140 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
141 Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 2010;7:448-58. [PMID: 20628345 DOI: 10.1038/nrgastro.2010.100] [Cited by in Crossref: 810] [Cited by in F6Publishing: 771] [Article Influence: 73.6] [Reference Citation Analysis]
142 Fishman JA, Grossi PA. Donor-derived infection--the challenge for transplant safety. Nat Rev Nephrol. 2014;10:663-672. [PMID: 25178971 DOI: 10.1038/nrneph.2014.159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
143 Corrêa ASM, Lamarão LM, Vieira PCM, de Castro RBH, de Almeida NCC, de Castro JAA, de Lima MSM, Palmeira MK, Meireles ALLP, Burbano RR. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil. PLoS One 2018;13:e0208414. [PMID: 30566494 DOI: 10.1371/journal.pone.0208414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 Shyamala V, Arcangel P, Cottrell J, Coit D, Medina-Selby A, McCoin C, Madriaga D, Chien D, Phelps B. Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays. J Clin Microbiol 2004;42:5199-204. [PMID: 15528715 DOI: 10.1128/JCM.42.11.5199-5204.2004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
145 Bydon M, Abt NB, Macki M, Brem H, Huang J, Bydon A, Tamargo RJ. Preoperative anemia increases postoperative morbidity in elective cranial neurosurgery. Surg Neurol Int 2014;5:156. [PMID: 25422784 DOI: 10.4103/2152-7806.143754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
146 Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16-9. [PMID: 10390452 DOI: 10.1136/bmj.319.7201.16] [Cited by in Crossref: 227] [Cited by in F6Publishing: 176] [Article Influence: 10.3] [Reference Citation Analysis]
147 Westphal GA, Garcia VD, Souza RL, Franke CA, Vieira KD, Birckholz VR, Machado MC, Almeida ER, Machado FO, Sardinha LA, Wanzuita R, Silvado CE, Costa G, Braatz V, Caldeira Filho M, Furtado R, Tannous LA, Albuquerque AG, Abdala E; Associação de Medicina Intensiva Brasileira., Associação Brasileira de Transplante de Órgãos. Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva 2016;28:220-55. [PMID: 27737418 DOI: 10.5935/0103-507X.20160049] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
148 Yates EW, Boden RA, Suvarna K, Stockley I. Fresh osteochondral allograft with soft tissue reconstruction for open knee trauma: A 20-year follow-up. Ann R Coll Surg Engl 2016;98:e34-6. [PMID: 26829669 DOI: 10.1308/rcsann.2016.0059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]